← Back to Search

SUPPORT-D Program for Alzheimer's Disease

Q: Is there an ongoing opportunity to join this trial?

<p>As indicated on the clinicaltrials.gov platform, this medical trial is still recruiting patients and commenced in December of 2022; further updates were made to the study that same month.</p>

Q: What is the current tally of participants in this research endeavor?

<p>Affirmative, the details posted on clinicaltrials.gov indicate that this trial has begun recruiting participants. The initial posting was made December 1st 2022 and recently updated on the same day. 60 patients are required to be recruited from a single medical centre.</p>

N/A

Waitlist Available

Led By Diana M Layne, PhD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years old or older

Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score < 4)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at study completion, an average of 8 weeks

Awards & highlights

Study Summary

This trial tests a nurse-led intervention to help improve quality of life for people living with Alzheimer's and their caregivers, and to make them safer in the community.

Who is the study for?

This trial is for adults over 18 with Alzheimer's or suspected Alzheimer's (FAST score < 4), who can read and speak English. It includes non-paid caregivers providing care to someone with Alzheimer's. Those unable to consent or unwilling to participate are excluded.Check my eligibility

What is being tested?

The study tests a nurse-led SUPPORT-D program, designed to improve advanced care planning and quality of life for people living with Mild Cognitive Impairment/Alzheimer’s and their caregivers.See study design

What are the potential side effects?

Since this intervention involves educational support rather than medication, traditional side effects are not expected; however, participants may experience emotional distress or fatigue from discussions about future care planning.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with Alzheimer's or it is suspected (my functioning is still fairly high).

Select...

I can read and speak English.

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at study completion, an average of 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at study completion, an average of 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, an average of 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention Measure (AIM) score

Appropriateness of Intervention score

Change Zarit caregiver burden score

+15 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: SUPPORT-D GroupExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

A Program of SUPPORT-D (dementia)

2023

N/A

~60

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH

99 Previous Clinical Trials

36,251 Total Patients Enrolled

National Center for Advancing Translational Sciences (NCATS)NIH

320 Previous Clinical Trials

401,672 Total Patients Enrolled

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,202 Total Patients Enrolled

Media Library

A Program of SUPPORT-D (dementia) Clinical Trial Eligibility Overview. Trial Name: NCT05501119 — N/A

Alzheimer's Disease Research Study Groups: SUPPORT-D Group

Alzheimer's Disease Clinical Trial 2023: A Program of SUPPORT-D (dementia) Highlights & Side Effects. Trial Name: NCT05501119 — N/A

A Program of SUPPORT-D (dementia) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05501119 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing opportunity to join this trial?

"As indicated on the clinicaltrials.gov platform, this medical trial is still recruiting patients and commenced in December of 2022; further updates were made to the study that same month."

Answered by AI

What is the current tally of participants in this research endeavor?

"Affirmative, the details posted on clinicaltrials.gov indicate that this trial has begun recruiting participants. The initial posting was made December 1st 2022 and recently updated on the same day. 60 patients are required to be recruited from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

Diana Layne, PhD, RN, CPHQ 2023. "SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05501119.